Armin Ahmadi, PhD
@arahmadi.bsky.social
Postdoctoral research fellow at UC San Diego
Division of Nephrology-Hypertension
Division of Nephrology-Hypertension
Reposted by Armin Ahmadi, PhD
Home-based #Exercise Improves #Muscle #Oxidative Capacity in #Kidney #Disease
#VisualAbstract by Husam Alzayer
https://www.kireports.org/article/S2468-0249(25)00755-7/fulltext
Gwenaelle Begue Armin Ahmadi, PhD Bob Roshanravan
#VisualAbstract by Husam Alzayer
https://www.kireports.org/article/S2468-0249(25)00755-7/fulltext
Gwenaelle Begue Armin Ahmadi, PhD Bob Roshanravan
January 12, 2026 at 2:01 PM
Reposted by Armin Ahmadi, PhD
A study in #ASNKidney360 finds that tubule biomarkers may reveal microvascular pathways linking kidney dysfunction to cardiovascular risk beyond eGFR or ACR. Check it out: kidney.pub/KID0970
@arahmadi.bsky.social
@arahmadi.bsky.social
October 24, 2025 at 6:00 PM
A study in #ASNKidney360 finds that tubule biomarkers may reveal microvascular pathways linking kidney dysfunction to cardiovascular risk beyond eGFR or ACR. Check it out: kidney.pub/KID0970
@arahmadi.bsky.social
@arahmadi.bsky.social
Reposted by Armin Ahmadi, PhD
Recent publication by LAUNCH affiliate @arahmadi.bsky.social and alumnus Heiko Yang: Packed Red Blood Cell and Whole Blood Perfusates during Ex-Vivo Normothermic Perfusion for Assessment of High-Risk Donor Kidneys. Congrats Armin and Heiko! pubmed.ncbi.nlm.nih.gov/40333014/ @broshanr.bsky.social
Packed Red Blood Cell and Whole Blood Perfusates during Ex-Vivo Normothermic Perfusion for Assessment of High-Risk Donor Kidneys - PubMed
Compared to WB, PRBC perfusion is superior in mitigating post-ischemia damage and facilitating function and metabolic recovery of high-risk kidneys subjected to long CITs during a three-hour EVNP.
pubmed.ncbi.nlm.nih.gov
June 4, 2025 at 5:06 PM
Recent publication by LAUNCH affiliate @arahmadi.bsky.social and alumnus Heiko Yang: Packed Red Blood Cell and Whole Blood Perfusates during Ex-Vivo Normothermic Perfusion for Assessment of High-Risk Donor Kidneys. Congrats Armin and Heiko! pubmed.ncbi.nlm.nih.gov/40333014/ @broshanr.bsky.social
Reposted by Armin Ahmadi, PhD
Compared to WB, PRBC perfusion is superior in mitigating post-ischemia damage and facilitating function and metabolic recovery of high-risk kidneys subjected to long CITs during a three-hour EVNP. https://bit.ly/KID0815
#ASNKidney360
@arahmadi.bsky.social
@broshanr.bsky.social
#ASNKidney360
@arahmadi.bsky.social
@broshanr.bsky.social
May 16, 2025 at 7:00 PM
Compared to WB, PRBC perfusion is superior in mitigating post-ischemia damage and facilitating function and metabolic recovery of high-risk kidneys subjected to long CITs during a three-hour EVNP. https://bit.ly/KID0815
#ASNKidney360
@arahmadi.bsky.social
@broshanr.bsky.social
#ASNKidney360
@arahmadi.bsky.social
@broshanr.bsky.social
Reposted by Armin Ahmadi, PhD
NIH research saves lives and powers the economy. In California, it supports ~56K jobs and $13.55B in economic activity. Cuts to NIH funding puts lives and livelihoods in jeopardy. Congress must act—tell your lawmakers to save medical research funding now! ucdav.is/4i4zFfB #SaveNIHresearch
February 19, 2025 at 6:48 PM
NIH research saves lives and powers the economy. In California, it supports ~56K jobs and $13.55B in economic activity. Cuts to NIH funding puts lives and livelihoods in jeopardy. Congress must act—tell your lawmakers to save medical research funding now! ucdav.is/4i4zFfB #SaveNIHresearch
Reposted by Armin Ahmadi, PhD
Machine Perfusion in Deceased Donor Kidney Transplantation: Editorial Summary of a Cochrane Review by @samjtingle.bsky.social and Colin Hugh Wilson
https://bit.ly/AJKD25TingleCCS (FREE)
https://bit.ly/AJKD25TingleCCS (FREE)
February 19, 2025 at 5:16 PM
Machine Perfusion in Deceased Donor Kidney Transplantation: Editorial Summary of a Cochrane Review by @samjtingle.bsky.social and Colin Hugh Wilson
https://bit.ly/AJKD25TingleCCS (FREE)
https://bit.ly/AJKD25TingleCCS (FREE)
Reposted by Armin Ahmadi, PhD
Reposted by Armin Ahmadi, PhD
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials
https://bit.ly/42Hkwwh #OpenAccess
#VisualAbstract
https://bit.ly/42Hkwwh #OpenAccess
#VisualAbstract
February 13, 2025 at 5:00 PM
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials
https://bit.ly/42Hkwwh #OpenAccess
#VisualAbstract
https://bit.ly/42Hkwwh #OpenAccess
#VisualAbstract
Reposted by Armin Ahmadi, PhD
Incretins are regulators of insulin secretion and glucose homeostasis metabolized by DPP-4. This study found that incretin response to oral glucose is preserved or augmented in moderate-to-severe CKD, without apparent differences in circulating DPP-4 concentration or activity. bit.ly/CJASN0566
January 16, 2025 at 7:14 PM
Incretins are regulators of insulin secretion and glucose homeostasis metabolized by DPP-4. This study found that incretin response to oral glucose is preserved or augmented in moderate-to-severe CKD, without apparent differences in circulating DPP-4 concentration or activity. bit.ly/CJASN0566
Reposted by Armin Ahmadi, PhD
Our randomized crossover trial of nicotinamide riboside (NR) and co-enzyme Q10 (CoQ10) in sedentary patients with chronic kidney disease (CKD) is now published in CJASN.
Read the full article:https://journals.lww.com/cjasn/abstract/9900/a_pilot_trial_of_nicotinamide_riboside_and.533.aspx#
Read the full article:https://journals.lww.com/cjasn/abstract/9900/a_pilot_trial_of_nicotinamide_riboside_and.533.aspx#
A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on... : Clinical Journal of the American Society of Nephrology
r efficacy in CKD.
Methods:
We conducted a pilot randomized, double-blind, placebo-controlled crossover trial comparing the effects of 1200 mg/day of coenzyme Q10 (CoQ10) or 1000 mg/day of nicotina...
journals.lww.com
January 24, 2025 at 7:29 PM
Our randomized crossover trial of nicotinamide riboside (NR) and co-enzyme Q10 (CoQ10) in sedentary patients with chronic kidney disease (CKD) is now published in CJASN.
Read the full article:https://journals.lww.com/cjasn/abstract/9900/a_pilot_trial_of_nicotinamide_riboside_and.533.aspx#
Read the full article:https://journals.lww.com/cjasn/abstract/9900/a_pilot_trial_of_nicotinamide_riboside_and.533.aspx#
Reposted by Armin Ahmadi, PhD
Impaired Incretin Homeostasis in Nondiabetic... : Clinical Journal of the American Society of Nephrology journals.lww.com/cjasn/fullte...
Impaired Incretin Homeostasis in Nondiabetic... : Clinical Journal of the American Society of Nephrology
with insulin response and coincided with persistently greater glucagon levels to oral glucose tolerance testing in CKD.Disruption in the incretin system and glucagon dynamics may contribute to metabol...
journals.lww.com
November 26, 2024 at 10:05 PM
Impaired Incretin Homeostasis in Nondiabetic... : Clinical Journal of the American Society of Nephrology journals.lww.com/cjasn/fullte...
Reposted by Armin Ahmadi, PhD
